Expanding Precision Oncology With Targeted Immunotherapy
Dr. Pedro Barata and Dr. Bridget Keenan discuss the innovative bioengineering allowing clinicians to target historically "immune-cold" tumors , the logistical evolution of bringing bispecific therapies safely into outpat





